This international one day conference, being organised by Lab Innovator, will examine how to patent treatment methods and diagnostics to protect innovations within personalised medicines. We are facing a paradigm shift in the global life science industry today. Personalised medicines allow biotech and pharmaceutical companies to deliver customised drugs or treatment options that match each individual’s genetic make-up.
It is important to develop an IP strategy focusing on your personalised medicine innovations where genomic relationships are being used to customise a drug for specific target diseases. The key to success is the combination. Narrow claims protect your biotech invention and will successfully exclude your competitors to exploit the claimed genomic relationship in your patents.
We are pleased being able to present the pioneers within personalised drugs such as DeCode Genetics, Affymetrix, Myriad Genetics, IBM Healthcare & Life Sciences, Sanofi-Aventis and UCB Group sharing their best experiences to protect your personalised medicine innovations in the era of post-genomics.
Make your reservation no later than July 3rd to reduce exclusive early booking discount 15 % on the full conference fee 9.500 DKK + 25 % VAT. |